Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson : SA to Soon Administer Over 300,000 Covid-19 Vaccines a Day

07/29/2021 | 12:06pm EDT

Government is gearing up to administer over 300 000 COVID-19 vaccination inoculations a day, with an unprecedented amount of doses set to arrive in the country in the next coming days and weeks.

The delivery of the vaccines will soon see the country have enough stock for about 50 days.

As of Thursday, the country had administered over 7 million doses. Of these, 903 000 were Johnson & Johnson doses exclusively for essential public services sectors like social development, the police and military personnel. Since 17 May, 4.3 million Pfizer first doses and 1.3 million second doses have been administered.

Department of Health Deputy Director-General for the National Health Insurance, Dr Nicholas Crisp, emphasised this during a digital media webinar on how government can leverage social media in the fight against COVID-19.

The Government Communication and Information System (GCIS) and the University of Johannesburg's (UJ) Institute hosted Thursday's webinar.

He said: "This week is the least vaccines we've ever had in the system".

"We are geared to do well over 300 000 vaccinations a day. We have this little window of this week where we have not yet received the Johnson & Johnson vaccine.

This was set to begin changing from Saturday when the country begins to receive large Pfizer consignments.

"We have received some vaccines last Sunday - another 960 000 doses - but the main vaccines will really start to arrive on Saturday, Sunday, Tuesday, and the week after that," he said.

A Johnson & Johnson vaccine batch could also arrive this Friday, but this is yet to be confirmed.

Once these vaccines arrive, the country could have at least 50 days of vaccines available. This would exponentially bolster South Africa's vaccination programme and see it go "flat out".

"It's those within the groups that are over the age of 60 and 50, that we must continue to reach and our messaging must really continue to ask the young people to bring their parents and their grandparents for vaccinations," he said.

He said while some people could walk into vaccination sites and receive jabs, it was still preferred that individuals registered on the designated Electronic Vaccination Data System (EVDS) self-registration portal.

"There's a race against time, as I said, but the biggest race is to get as many of the older population as possible vaccinated as we possibly can," said Crisp.

Copyright SAnews.gov.za. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

Stocks mentioned in the article
ChangeLast1st jan.
JOHNSON & JOHNSON -0.28% 164.75 Delayed Quote.4.68%
PFIZER, INC. -1.30% 43.89 Delayed Quote.20.81%
All news about JOHNSON & JOHNSON
05:25pMODERNA : U.S. administers about 384.9 mln doses of COVID-19 vaccines -CDC
09/17Moderna Drops Ahead of FDA Committee COVID-19 Booster Decision
09/17CDC DATA : Moderna vaccine has edge in preventing COVID-19 hospitalizations
09/17JOHNSON & JOHNSON : Slovenia starts mandatory vaccination for government workers
09/17JOHNSON & JOHNSON : Janssen Presents Results from Phase 1b/2 NORSE Study in Pati..
09/17JOHNSON & JOHNSON : GSA Director Lauded for Luring More People to Get Covid-19 V..
09/17JOHNSON & JOHNSON : Unit Janssen's Schizophrenia Drug Gets European Medicines Ag..
09/17J&J's Janssen Gets CHMP Backing for Twice-Yearly Schizophrenia Treatment
09/16JOHNSON & JOHNSON : to Host Investor Conference Call on Third-Quarter Results
09/16PFIZER : FDA Sees Current COVID-19 Vaccine Protocol as Still Effective Ahead of ..
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 94 407 M - -
Net income 2021 22 809 M - -
Net Debt 2021 1 880 M - -
P/E ratio 2021 19,1x
Yield 2021 2,53%
Capitalization 434 B 434 B -
EV / Sales 2021 4,61x
EV / Sales 2022 4,42x
Nbr of Employees 134 500
Free-Float 84,3%
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 164,75 $
Average target price 185,83 $
Spread / Average Target 12,8%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.20.81%246 078
NOVO NORDISK A/S50.80%232 556
ABBVIE INC.0.54%190 378